Direct comparison
Modifier 59 vs 91: Lab Repeat or Bundling?
Modifier 91 is for a same-day repeat of a CLFS lab test; 59 is for two bundled procedure codes. Both bypass NCCI edits. Modifier 76 expressly does not.
Ask about Modifier 59 vs 91: Lab Repeat or Bundling?
Answers are drawn from this comparison and the rest of the CASRAI corpus, with a link to every source.
Answers are AI-generated from CASRAI’s own published pages and can be wrong, so check the linked sources before relying on one; your question is logged without personal data — never sold, never used to train a third-party model — to show us what CASRAI is missing, so please do not type personal or confidential details. How we use this
How do Modifier 91, Modifier 59 compare side by side?
The table below compares Modifier 91, Modifier 59 across 11 procurement-relevant dimensions, from the decision in one line through a clia-waived test.
Side-by-side comparison
| Dimension | Modifier 91 | Modifier 59 |
|---|---|---|
| The decision in one line | The same lab test, run again the same day, because treatment needs multiple results. | Two different codes on the same claim that NCCI bundles, where the second was genuinely distinct. |
| What it is limited to | Laboratory tests paid under the clinical laboratory fee schedule. Chapter 16 §100.5.1 states this twice, and the second statement is exclusive: the modifiers "may be used only for laboratory tests paid under the clinical laboratory fee schedule". | Non-E/M procedure codes generally. Barred on E/M services and on CPT 77427. |
| The trigger | It is "necessary to obtain multiple results in the course of treatment" — serial values that inform care, such as a repeated measurement tracking a response. | An NCCI procedure-to-procedure edit with a correct-coding modifier indicator of 1, plus a separate encounter, site or specimen, or one of three narrow same-encounter exceptions. |
| What it must not be used for | Reruns to confirm an initial result; repeats caused by problems with specimens or equipment; any case where a normal, one-time reportable result is all that is required; and any test with a standard code describing the series of results, such as glucose tolerance or evocative and suppression testing (Ch. 16 §100.5.1). | Clearing an edit that the record does not actually support, or asserting distinctness merely because the two code descriptors read differently. |
| NCCI PTP status | PTP-associated. It appears on the NCCI list under "other modifiers" alongside 27, 59 and the X modifiers, so it can bypass a CCMI 1 edit. | PTP-associated. |
| The asymmetry with modifier 76 | Modifier 76 is expressly not a PTP-associated modifier — NCCI Policy Manual Ch. 1 §E names 22, 76 and 77 and states their use "does not bypass an NCCI PTP edit". So for a repeated CLFS lab test, 91 both describes the repeat and clears the edit; 76 would do neither. | Same asymmetry from the other direction: reaching for 76 after a bundling denial cannot work, whatever the clinical facts. |
| Repeat of a panel component | Where a laboratory performs all tests in an organ or disease panel it reports the panel code; if one component is then repeated as a medically reasonable and necessary service the same day, the code for the repeat may be reported with 91 appended (NCCI PM Ch. 1 §N). | Not the mechanism for this. The panel rule is specifically a modifier 91 rule. |
| Does a different diagnosis matter? | It is not the test. What matters is that multiple results were needed in the course of treatment, and that the repeat was not a confirmation, a re-run or an equipment problem. | A different diagnosis is neither required nor adequate — CMS states both. |
| Anatomic modifiers | It does not replace them. Noridian lists RT, LT, 50, E1-E4, FA, F1-F9, TA and T1-T9 as modifiers 91 does not substitute for. | Same rule. Where an anatomic modifier fits, use it rather than 59. |
| The compliance exposure | Named explicitly: "Improper use of modifiers is likely to indicate a fraudulent or abusive circumstance", with contractors told to emphasise the narrow application and refer evidence of excessive use to a Program Integrity Unit (Ch. 16 §100.5.1). | A long-standing audit target across OIG and contractor medical review, on the same underlying theory: a modifier that unlocks payment is worth checking. |
| A CLIA-waived test | If the entity holds a valid waiver certificate, modifier QW is appended as well; QW and 91 answer different questions and do not replace each other. | Not applicable. |
Common questions
Common questions about Modifier 91 vs Modifier 59
What is the difference between modifier 59 and modifier 91?
+
Domain. Modifier 91 reports a clinical diagnostic laboratory test repeated on the same day for the same patient, and only for tests paid under the clinical laboratory fee schedule. Modifier 59 reports that two different procedure codes bundled by an NCCI edit were genuinely distinct services. If you are running the same test twice, that is 91. If you are billing two different codes that bundle, that is 59 or a more specific X modifier.
Can I use modifier 59 on a repeat lab test instead of 91?
+
Claims Processing Manual Chapter 16, section 100.5.1, names modifiers 59 and 91 together for tests performed more than once on the same day, then specifies that the 91 modifier is the one used for tests paid under the clinical laboratory fee schedule. For a repeated CLFS test, 91 is the designated and expected modifier, and Noridian’s Part B policy lists using 59 where another modifier such as 76 or 91 is more appropriate as an incorrect use. Reaching past 91 for 59 invites a question you do not need to answer.
Is modifier 91 or modifier 76 the right one for a repeated test?
+
For a clinical laboratory test, 91. Noridian’s modifier 76 page states plainly that 76 is "not appropriate with laboratory codes (append modifier 91)". The mechanical reason matters too: modifier 91 is an NCCI PTP-associated modifier and can bypass a bundling edit, while modifiers 22, 76 and 77 are expressly not PTP-associated and cannot. On a repeated lab test, 76 would neither describe the situation correctly nor clear an edit.
The lab had to re-run the test because the first specimen was compromised. Can I bill it with 91?
+
No. Chapter 16, section 100.5.1, excludes exactly this: the modifiers may not be used when tests are rerun to confirm initial results, when there are problems with specimens or equipment, or for any other reason where a normal one-time reportable result is all that is required. The repeat has to exist because multiple results were needed in the course of treatment, not because the first attempt failed.
Can I use modifier 91 for a glucose tolerance test?
+
No. The manual excludes cases where standard HCPCS codes already describe the series of results, and names glucose tolerance tests and evocative or suppression testing as examples. The series code already accounts for the multiple draws; appending 91 to component codes duplicates what the series code pays for.
A panel was performed and one component was repeated later the same day. How is that billed?
+
NCCI Policy Manual Chapter 1, section N, addresses this directly. Where a laboratory performs all the tests in an organ or disease specific panel it reports the panel code; if one of those component tests is then repeated as a medically reasonable and necessary service on the same date, the code corresponding to the repeat may be reported with modifier 91 appended. Chapter 10 of the same manual covers the panel rules in more detail.
Does modifier 91 bypass an NCCI edit?
+
Yes, where the edit’s correct-coding modifier indicator is 1 and the criteria for the modifier are genuinely met. Modifier 91 appears on the NCCI PTP-associated modifier list under "other modifiers", alongside 27, 59, XE, XS, XP and XU. This is the asymmetry worth remembering: 91 bypasses edits, 76 does not.
Going deeper
